GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » Cyclically Adjusted PS Ratio

Pulike Biological Engineering (SHSE:603566) Cyclically Adjusted PS Ratio : 5.41 (As of Jun. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Pulike Biological Engineering's current share price is ¥14.54. Pulike Biological Engineering's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥2.69. Pulike Biological Engineering's Cyclically Adjusted PS Ratio for today is 5.41.

The historical rank and industry rank for Pulike Biological Engineering's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:603566' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.36   Med: 8.62   Max: 12.49
Current: 5.47

During the past years, Pulike Biological Engineering's highest Cyclically Adjusted PS Ratio was 12.49. The lowest was 5.36. And the median was 8.62.

SHSE:603566's Cyclically Adjusted PS Ratio is ranked worse than
51.49% of 505 companies
in the Biotechnology industry
Industry Median: 5.3 vs SHSE:603566: 5.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pulike Biological Engineering's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥0.690. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥2.69 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pulike Biological Engineering Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pulike Biological Engineering's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering Cyclically Adjusted PS Ratio Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 10.60 8.47

Pulike Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.89 8.87 8.00 8.47 6.48

Competitive Comparison of Pulike Biological Engineering's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Pulike Biological Engineering's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's Cyclically Adjusted PS Ratio falls into.



Pulike Biological Engineering Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pulike Biological Engineering's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=14.54/2.69
=5.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulike Biological Engineering's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pulike Biological Engineering's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.69/115.2271*115.2271
=0.690

Current CPI (Mar. 2024) = 115.2271.

Pulike Biological Engineering Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.370 98.200 0.434
201409 0.662 98.900 0.771
201412 0.436 99.000 0.507
201503 0.541 99.900 0.624
201506 0.743 99.500 0.860
201509 0.446 100.500 0.511
201512 0.343 100.600 0.393
201603 0.373 102.200 0.421
201606 0.402 101.400 0.457
201609 0.555 102.400 0.625
201612 0.491 102.600 0.551
201703 0.396 103.200 0.442
201706 0.396 103.100 0.443
201709 0.385 104.100 0.426
201712 0.476 104.500 0.525
201803 0.448 105.300 0.490
201806 0.448 104.900 0.492
201809 0.453 106.600 0.490
201812 0.543 106.500 0.587
201903 0.409 107.700 0.438
201906 0.593 107.700 0.634
201909 0.478 109.800 0.502
201912 0.575 111.200 0.596
202003 0.585 112.300 0.600
202006 0.758 110.400 0.791
202009 0.717 111.700 0.740
202012 0.875 111.500 0.904
202103 0.995 112.662 1.018
202106 0.848 111.769 0.874
202109 0.759 112.215 0.779
202112 0.912 113.108 0.929
202203 0.784 114.335 0.790
202206 0.878 114.558 0.883
202209 0.982 115.339 0.981
202212 1.140 115.116 1.141
202303 0.911 115.116 0.912
202306 0.869 114.558 0.874
202309 0.918 115.339 0.917
202312 0.893 114.781 0.896
202403 0.690 115.227 0.690

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pulike Biological Engineering  (SHSE:603566) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pulike Biological Engineering Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines